Treatments for Diabetes 1800-2016

Timeline created by ruschtas
  • Bernard's Discovery

    Bernard's Discovery
    Bernard discovered that that the liver stored glycogen and secreted a sugary substance in the blood. This man was the first to link diabetes and glycogen metabolism.
  • Langerhans's Discovery

    Langerhans's Discovery
    Langerhans found that the pancreas held two types of cells. These cells were later found to help produce the hormone insulin
  • Boucherdat's Discovery

    Boucherdat's Discovery
    Boucherdat noticed the disappearance of sugar in the urine of his diabetes patients during the food rationing in Paris. He formulated the idea of individualized diets.
  • Frederick Banting

    Frederick Banting
    Banting had a new idea on how to find not only the cause but a treatment for the so-called "sugar disease". He also realized that the pancreas' digestive juice was destroying the islets of Langerhans hormone before it could be isolated.
  • Inuslin Extract Purification

    Inuslin Extract Purification
    Macleod assigned chemist James Bertram Collip to purify the insulin extract. This injection lowered his blood sugar and cleared his urine of sugars and other signs of disease.
  • Commercial Production of Insulin

    Commercial Production of Insulin
    During this year, Eli Lilly and Company began to commercially produce and sell insulin. Years after, they developed a variety of slower-acting insulins. The first one was protamine insulin .
  • Rachmiel Levine's Discovery

    Rachmiel Levine's Discovery
    Levine discovered that insulin works like a key. Therefore, it transports glucose into cells
  • Syring Discovery

    Syring Discovery
    In this year, Becton Dickinson and Company began the production of a standardized insulin syringe designed and approved by the American Diabetes Association.
  • Tablet Testing

    Tablet Testing
    During this year, tablets for testing urine glucose became widely available and urine test strips appear over th next fifty years.
  • Oral medications

    Oral medications
    Sulfonylureas, oral medications that stimulate the pancreas to release more insulin, became available.
  • Solomon Berson and Rosalyn Yalow's Discovery

    Solomon Berson and Rosalyn Yalow's Discovery
    During this year, these two individuals used radioimmunoassay technology to develop a method for measuring insulin in the blood. They noticed that some people with diabetes still make their own insulin, and they identify "insulin dependent" (type 1) and "non-insulin-dependent" (type 2) diabetes.
  • FIrst successful pancreas transplant

    FIrst successful pancreas transplant
    Scientists at the University of Minnesota Hospital completed the first successful pancreas transplant on an animal.
  • Insulin pumps

    Insulin pumps
    During this year, the first insulin pumps were developed. This development, and several others, provides patients with much greater control and flexibility in the management of their diabetes.
  • Insulin receptors

    Insulin receptors
    During this year, insulin receptors were discovered on cell membranes. This discovery raised the possibility that missing or defective insulin receptors may prevent glucose from entering the cells. This contributes to the insulin resistance of type 2 diabetes.
  • First insulin pen

    First insulin pen
    During this year, the first insulin pen delivery system was introduced to consumers.
  • External insulin pump

    External insulin pump
    External insulin pumps were created to allow closer control and freedom from multiple injections. More sophisticated insulin analogues were introduced to offer faster action, less risk of reactions and more flexibility for diabetes management. The analogues allowed physicians the ability to customize treatment, reduce side effects, and have improved outcomes.
  • Byetta

    Exenatide (Byetta) is approved in the United States as a first-in-class drug to treat type 2 diabetes. This is an injectable drug works to increase insulin production in response to blood glucose levels.
  • Invokana

    During this year, Invokana was the first in a new class of drugs known as the SGLT-2 inhibitors for lowering elevated blood sugar in patients with type 2 diabetes. This inhibitors block the activity of sodium glucose transport proteins in the kidney, reducing glucose re-uptake and increasing secretion of glucose in the urine.